Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | NFIL3 |
| Upstream (Parents) |
|---|
| (<<) ADCY3 → NFIL3 |
| (<<) ANGPTL4 → NFIL3 |
| (<<) ELF4 → NFIL3 |
| (<<) GPX3 → NFIL3 |
| (<<) HES1 → NFIL3 |
| (<<) HLA-A → NFIL3 |
| (<<) IL6 → NFIL3 |
| (<<) KLF2 → NFIL3 |
| (<<) MAP3K8 → NFIL3 |
| (<<) PHGDH → NFIL3 |
| (<<) PSAT1 → NFIL3 |
| (<<) PTEN → NFIL3 |
| (<<) SPAG5 → NFIL3 |
| (<<) SPDEF → NFIL3 |
| (<<) TCF7L1 → NFIL3 |
| (<<) WWTR1 → NFIL3 |
| Downstream (Children) |
|---|
| NFIL3 → BCAM (>>) |
| NFIL3 → CALML5 (>>) |
| NFIL3 → CEBPB (>>) |
| NFIL3 → CEBPD (>>) |
| NFIL3 → EBP (>>) |
| NFIL3 → GAD1 (>>) |
| NFIL3 → GLI3 (>>) |
| NFIL3 → INVS (>>) |
| NFIL3 → KLF11 (>>) |
| NFIL3 → KLHL7 (>>) |
| NFIL3 → LGALS3 (>>) |
| NFIL3 → MMP12 (>>) |
| NFIL3 → MYO10 (>>) |
| NFIL3 → NCOA7 (>>) |
| NFIL3 → NDRG1 (>>) |
| NFIL3 → RAD51L3 (>>) |
| NFIL3 → RGS20 (>>) |
| NFIL3 → SLC25A25 (>>) |
| NFIL3 → SMAD3 (>>) |
| NFIL3 → SOCS3 (>>) |
| NFIL3 → SOD2 (>>) |
| NFIL3 → TEX10 (>>) |
| NFIL3 → TFF1 (>>) |
| NFIL3 → TNRC18 (>>) |
